Utah Medical Products, Inc.
UTMDNASDAQHealthcare● Active
$67.05
$-0.60(-0.89%)
Market Cap$213489212
P/E Ratio—
52W High$71.81
52W Low$52
Utah Medical Products, Inc. (UTMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · UTMD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $38.52M | $40.90M | $50.22M | $52.28M | $49.05M |
| Cost of Revenue | $18.64M | $16.76M | $20.19M | $20.09M | $18.14M |
| Gross Profit | $19.88M | $24.14M | $30.04M | $32.20M | $30.92M |
| Gross Margin %(computed) | 51.60% | 59.03% | 59.81% | 61.58% | 63.03% |
| Operating Expenses | |||||
| R&D Expenses | $0.67M | $0.81M | $0.56M | $0.49M | $0.53M |
| G&A Expenses | $0.00M | $3.67M | $11.02M | $10.41M | $10.10M |
| Total Operating Expenses | $8.47M | $10.55M | $13.26M | $12.41M | $12.04M |
| Operating Income | $11.40M | $13.59M | $16.78M | $19.79M | $18.88M |
| Operating Margin %(computed) | 29.60% | 33.23% | 33.40% | 37.85% | 38.49% |
| Interest Income | $0.00M | $3.37M | $0.00M | $0.66M | $0.17M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $14.11M | $16.80M | $20.09M | $20.66M | $19.06M |
| Income Tax Expense | $2.82M | $2.93M | $3.45M | $4.19M | $4.27M |
| Net Income | $11.29M | $13.87M | $16.64M | $16.47M | $14.79M |
| Net Margin %(computed) | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.41 | $3.96 | $4.57 | $4.53 | $4.05 |
| Wtd Avg Shares | 3.31M | 3.50M | 3.64M | 3.64M | 3.65M |
| EBITDA | $17.06M | $16.44M | $24.75M | $26.87M | $26.16M |
| EBITDA Margin %(computed) | 44.29% | 40.19% | 49.28% | 51.40% | 53.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Utah Medical Products, Inc. data
About Utah Medical Products, Inc. (UTMD) Income Statement
Utah Medical Products, Inc. (UTMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, UTMD reported revenue of $0.04B, gross profit of $0.02B (gross margin 51.60%), and net income of $0.01B — a net profit margin of 29.30%.
Frequently asked questions
UTMD · 4 questionsUtah Medical Products, Inc. (UTMD) reported revenue of $0.04B for 2025, down 5.8% year-over-year.
UTMD revenueUTMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08